Monthly reductions in seizure frequency of 90.9% among participants treated for ≥48 months in the OLE, with 38% achieving ≥1 year of seizure freedomNew X-TOLE OLE data analysis supports the ability to ...

Xenon Pharmaceuticals (XENE) announced new data highlighting its commitment in epilepsy, including interim 48-month data from its ongoing X-TOLE ...

Note: This feature is experimental and not supported. It may not work properly. It may break in a future version of Device OS. Beware! Also, this is the preview release 0.0.1, there may still be bugs.

A team of researchers has announced their observation and measurement of the decay of Xenon-124, the rarest ever recorded. It ...

Scientists are using anesthesia to probe the quantum roots of consciousness—and the research offers tantalizing evidence.

Seven posters to be presented, including new X-TOLE OLE data supporting the ability to attain and regain extended periods of seizure freedom with long-term use of azetukalnerData will also highlight ...

A month has gone by since the last earnings report for Xenon Pharmaceuticals (XENE). Shares have added about 9.7% in that ...

More information on Xenon’s AES 2025 presentations can be found here. A live webcast of the webinar will be available on the “ Investors ” section of Xenon's website and posted for replay following ...

Xenon, a company specializing in generative artificial intelligence (AI) solutions, announced on December 2 that it has signed a three-party ...

An international team of researchers have found a better way to separate two rare and important gases—xenon and krypton—that ...

Polarean’s FDA cleared coil achieves important milestone, expanding clinical reach XENOVIEW® 3T coil passes Philips ...

Key PointsResearchers have found a better way to separate two rare and important gases, xenon and krypton, using a zeolite material Industry will ...